Drug Profile
Etanercept biosimilar - Hanwha Chemical
Alternative Names: Davictrel; HD 203; MK-8953Latest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator Hanwha Chemical
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Ankylosing spondylitis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
Most Recent Events
- 10 Nov 2013 Hanwha Chemical completes enrolment in the phase I EAGLE-I-13 trial in Healthy volunteers in South Korea (NCT01894412)
- 03 Jul 2013 Hanwha Chemical initiates enrolment in the phase I EAGLE-I-13 trial in Healthy volunteers in South Korea (NCT01894412)
- 30 Jun 2013 Hanwha Chemical completes the phase I EAGLE-I-11 trial in Healthy volunteers in South Korea (NCT01431404)